 19. Previous or concurrent malignant tumor disease other than underlying tumor disease with the exception of cervical cancer in situ, adequately treated basal cell carcinoma or squamous cell carcinoma of the skin, superficial bladder tumors Ta, Tis, and T1 or any curatively treated tumors 5 years prior to enrolment 